Comments on“Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia”
jiang zuo ; zhao zi chu ;

..............page:737-740

yi xue lun wen ying wen zhai yao zhong zuo zhe shu ming yu zuo zhe dan wei de shu xie gui fan

..............page:740

Status of allogeneic hematopoietic stem cell transplantation for treatment of chronic myeloid leukemia in TKI era
liu qi fa ; xu na ;

..............page:741-744+748

Hot topics of chronic myeloid leukemia in tyrosine kinase inhibitor era
jiang zuo ;

..............page:745-748

Which is the best choice in treating chronic myeloid leukemia in chronic phase:the first or second generation of TKI?
wei xu dong ; mi rui hua ;

..............page:749-752

Status of autologous hematopoietic stem cell transplantation in the treatment of multiple myeloma in the new drug era
chen huan ; liu kai yan ;

..............page:753-756

2016 nian lin chuang xue ye xue za zhi zhuan lan zheng gao tong zhi

..............page:756

Clinical study on 5cases of chronic myelogenous leukemia with thrombocythemia onset
PENGShuyi;LIANG Ye;LUO Lin;LIU Lianjin;LI Zhongqing;LAI Yinghui;LIU Zhenfang;PENG Zhigang;LAI Yongrong;LUO Jun;Department of Hematology;the First Affiliated Hospital of Guangxi Medical University;

..............page:757-759

Comparison of the efficacy and safety of rituximab plus CHOP and CHOP alone regimens in patients with newly diagnosed diffuse large B-cell lymphoma
CHEN Yanxin;ZHENG Xiaoyun;LIU Tingbo;ZHENG Jing;ZHENG Zhihong;HU Jianda;Department of Hematology;Fujian Medical University Union Hospital;Fujian Institute of Hematology;State and Fujian Province Key Clinical Department;

..............page:760-763

Observation of the curative effect of rituximab combined with GDP regimen in the treatment of recurrent and refractory diffuse large B-cell lymphoma
BIN Yancheng;ZHANG Hua;LI Husheng;FENG Cui;LV Zhao;Department of Hematology;Guangxi Yulin City Red Cross Hospital;

..............page:764-766

Expression of T lymphocyte subsets and interleukin-6in patients with multiple myeloma
YANG Datian;YAO Fusheng;LIANG Hong;XU Haitao;PAN Ming;Department of Hematology;Anqing Hospital Affiliated to Anhui Medical Univesity;

..............page:767-768+773

Long-term outcome of splenectomy for 74adult patients with immune thrombocytopenia
LIU Xiaofan;SUN Chaoxia;WANG Zhijun;CHEN Yunfei;HUANG Yueting;LIU Wei;XUE Feng;ZHANG Lei;XU Maoqiang;YANG Renchi;Institute of Hematology & Blood Diseases Hospital;CAMS & PUMC;

..............page:769-773

Analysis of immune factors influencing the infection after chemotherapy in patients with aggressive non-Hodgkin’s lymphoma
GU Jun;SUN Huiping;LU Hongyu;ZHANG Jingfang;ZHAO Xuhong;ZHAO Di;DENG Xiaogang;CHEN Mei;Department of Hematology;Yangpu Hospital Affiliated to Tongji University;Ruijin Hospital;Shanghai Jiaotong University School of Medicine;

..............page:774-777

Combination therapy with recombinant human thrombopoietin and low-dose rituximab for corticosteroid-resistant/relapsed adult ITP:a multicenter clinical trial
LIU Xinguang;LIU Xiaofan;MENG Yuesheng;ZENG Qingshu;ZHOU Yuhong;ZHANG Mei;WANG Xiaomin;WANG Xin;GUO Nongjian;FANG Meiyun;ZHOU Fang;XU Ruirong;YUAN Chenglu;FENG Ying;YANG Renchi;QIN Ping;PENG Jun;HOU Ming;Department of Hematology;Qilu Hospital of Shandong University;Tianjin Hematonosis Hospital;Oingdao Municipal Hospital;The First Affiliated Hospital of Anhui Medical University;Zhejiang Traditional Chinese Medical Hospital;The First Affiliated Hospital of Xi’an Jiao Tong University;Xinjiang Autonomous Region People’s Hospital;Shandong Provincial Hospital;Ji’nan Central Hospital;The First Affiliated Hospital of Dalian Medical University;General Hospital of Jinan Military Area;Shandong Traditional Chinese Medical Hospital;Qingdao Central Hospital;The Second Affiliated Hospital of Guangzhou Medical College;

..............page:778-781

Efficiency of treatment with rituximab in immune platelet transfusion refractoriness:a case report and literature review
LIU Wenbin;WU Dijiong;YE Baodong;HU Huijin;ZHOU Yuhong;Department of Hematology;First Hospital Affiliated to Zhejiang Chinese Medical University;

..............page:782-783+787

A survey analysis of severe children with hemophilia A in Beijing and Hebei province
LI Kuixing;HUA Baolai;ZHOU Yin;XIAO Juan;ZHAO Yanwei;CHEN Chunrong;YU Minhong;Department of Hematology;Peking Union Medical College Hospital;Chinese Academy of Medical Sciences & Peking Union Medical College;

..............page:784-787

The change of cell abundance,cell cycle and DNA synthesis for G-MDSC in tumor
QIN Baoxiong;ZHAN Jinxi;LI Yun;WU Xueheng;PU Shiming;ZHOU Zuping;College of Life Science;Guangxi Normal University;

..............page:788-791

Efficacy comparison between decitabine alone,HAG and dectiabine+HAG regimen in older patients with acute myeloid leukemia
ZHAO Jianzhi;ZHOU Jianyao;HOU Tao;HAN Xiaowei;WANG Guofang;ZHU Junling;SUN Weidong;Department of Hematology;Shaoxing Central Hospital;

..............page:792-794+798

Effect of Berberine on proliferation and apoptosis of K562cells
PAN Liping;YUAN Wei;Department of Hematology;Yichang Central People’s Hospital;

..............page:795-798

Clinical study on reduced-dose dexamethason plus bortezomib in the treatment of elderly patients with multiple myeloma
xu li ; li han ; mo wen jian ; mao ping ;

..............page:799-800

Myelofibrosis and portal hypertension secondary to chronic myelomonocytic leukemia:a case report and literature review
sang tan ; zhou ya wei ; chang ya li ; zhao ; guo nong jian ; chen zuo ;

..............page:801-802

A case report of primary breast lymphoma and literature review
ren qing yu ; yang xing ; hou lan fen ;

..............page:803-805

jing gao zuo zhe

..............page:805

Twenty-three years surviving in a patient with del(5q)myelodysplastic syndrome
li pan pan ; li jun ; lin yu mei ;

..............page:806-807

A case of atypical chronic myelogenous leukemia transformed to acute leukemia in a short term and literature review
ye xiu peng ; bao shen ; li ye qiong ; guo ying ; wei yu ping ; ding jian hua ; zhi feng ; song li jun ; bai jie ; li fang ; jin li yuan ;

..............page:807-809

A case report of the significantly increased neutrophil count following combined allogeneic hematopoietic stem cells microtransplantation and chemotherapy treatment in an elderly patient with acute myeloid leukemia
liang bo ; zhou ya li ; chen yong sheng ; zhang xin hua ; yin xiao lin ; zhou tian hong ;

..............page:810-811

Advances in pathogenesis and treatment of atypical hemolytic uremic syndrome
wang zhao zuo ;

..............page:812-815

Rituximab for non-Hodgkin lymphoma--reviews and prospects
jiang wen qi ; chen ting chao ;

..............page:816-822

The role of platelets in PNH thrombosis
liu yi ; fu rong ;

..............page:823-826

Progress of CLOCK genes in hematoligic malignancies
yuan lin ; zhou jin ;

..............page:826-828